OPTN/SRTR 2021 Annual Data Report: COVID-19

Am J Transplant. 2023 Feb;23(2 Suppl 1):S475-S522. doi: 10.1016/j.ajt.2023.02.011.

Abstract

This chapter updates the COVID-19 chapter from the 2020 Annual Data Report with trends through February 12, 2022, and introduces trends in COVID-19-specific cause of death on the waiting list and posttransplant. Transplant rates remain at or above prepandemic levels for all organs, indicating a sustained transplantation system recovery following the initial 3-month disruption due to the onset of the pandemic. Posttransplant mortality and graft failure remain a concern in all organs, with rates surging corresponding to waves of the pandemic. Waitlist mortality due to COVID-19 is also a concern, particularly among kidney candidates. While the recovery of the transplantation system has been sustained in the second year of the pandemic, ongoing efforts should focus on reducing posttransplant and waitlist mortality due to COVID-19, and graft failure.

Keywords: COVID-19; solid organ transplant; transplant outcomes; waitlist mortality.

MeSH terms

  • COVID-19* / epidemiology
  • Graft Survival
  • Humans
  • Liver Transplantation*
  • Lung Transplantation*
  • Tissue Donors
  • Tissue and Organ Procurement*
  • United States / epidemiology
  • Waiting Lists